カテゴリ： MarketLine, アメリカ, 企業調査

Johnson & Johnson：企業の戦略・SWOT・財務情報

◆英語タイトル：Johnson & Johnson - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4422
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：65
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Johnson & Johnson – Strategy, SWOT and Corporate Finance Report
Summary

Johnson & Johnson – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Johnson & Johnson (J&J or ‘the company’) is one of the world’s largest providers of diverse health care products. The company is engaged in the research, development, manufacture and sale of consumer health care products, pharmaceuticals, and medical devices. It provides pharmaceuticals in the areas of immunology, cancer, neuroscience, infectious, cardiovascular and metabolic diseases areas. J&J has business presence across the Americas, Europe, Asia-Pacific and Africa. J&J distributes its pharmaceutical products, medical devices and consumer products to retailers, wholesalers, health care professionals and hospitals and through a network of retail outlets and distributors. J&J is headquartered in New Brunswick, New Jersey, the US.

Scope

- Detailed information on Johnson & Johnson required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Johnson & Johnson in the form of a SWOT analysis
- An in-depth view of the business model of Johnson & Johnson including a breakdown and examination of key business segments
- Intelligence on Johnson & Johnson’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Johnson & Johnson, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Johnson & Johnson and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Johnson & Johnson as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Johnson & Johnson’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Johnson & Johnson: Company Overview 9
Johnson & Johnson: Overview and Key Facts 9
Johnson & Johnson: Overview 9
Johnson & Johnson: Key Facts 9
Johnson & Johnson: Key Employees 10
Johnson & Johnson: Key Employee Biographies 12
Johnson & Johnson: Major Products and Services 19
Johnson & Johnson: Company History 21
Johnson & Johnson: Management Statement 34
Johnson & Johnson: Locations and Subsidiaries 35
Johnson & Johnson: Key Competitors 36
Johnson & Johnson: Company Analysis 37
Johnson & Johnson: Business Description 37
Johnson & Johnson: SWOT Analysis 39
Johnson & Johnson: SWOT Overview 39
Johnson & Johnson: Strengths 39
Johnson & Johnson: Weaknesses 41
Johnson & Johnson: Opportunities 42
Johnson & Johnson: Threats 43
Johnson & Johnson: Corporate Financial Deals Activity 46
Johnson & Johnson: Financial Deals Overview 46
Johnson & Johnson: Targets and Partners 48
Johnson & Johnson: Top Deals 2014 – 2018YTD* 49
Johnson & Johnson: Advisors 50
Johnson & Johnson: Top Legal Advisors 50
Johnson & Johnson: Top Financial Advisors 50
Johnson & Johnson: Mergers and Acquisitions 52
Johnson & Johnson: Capital Raising 53
Johnson & Johnson: Divestments 54
Johnson & Johnson: Recent Developments 55
Johnson & Johnson: News and Events Summary 55
Johnson & Johnson: Contracts 58
Johnson & Johnson: Corporate Governance 59
Johnson & Johnson: Financial Deals 60
Johnson & Johnson: Financial Performance 60
Johnson & Johnson: Regulatory and Legal Events 60
Johnson & Johnson: Strategy and Operations 61
Appendix 63
Contact Us 63
Methodology 63
About MarketLine 64

List of Tables
Table 1: Johnson & Johnson: Key Facts
Table 2: Johnson & Johnson: Key Employees
Table 3: Johnson & Johnson: Locations and Subsidiaries
Table 4: Johnson & Johnson: Key Competitors
Table 5: Johnson & Johnson: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Johnson & Johnson: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Johnson & Johnson: M&A Average Deal Size - Value (US$m)
Table 8: Johnson & Johnson: Targets and Partners
Table 9: Johnson & Johnson: Top Deals 2014 - 2018YTD*
Table 10: Johnson & Johnson: Legal Advisor Ranking by Value (US$m)
Table 11: Johnson & Johnson: Financial Advisor Ranking by Value (US$m)
Table 12: Johnson & Johnson: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Johnson & Johnson: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Johnson & Johnson: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Johnson & Johnson: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Johnson & Johnson: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Johnson & Johnson: Divestments by Geography (2014 - YTD*2018)
Table 18: Johnson & Johnson: News and Events Summary
Table 19: Johnson & Johnson: Contracts
Table 20: Johnson & Johnson: Corporate Governance
Table 21: Johnson & Johnson: Financial Deals
Table 22: Johnson & Johnson: Financial Performance
Table 23: Johnson & Johnson: Regulatory and Legal Events
Table 24: Johnson & Johnson: Strategy and Operations

List of Figures
Figure 1: Johnson & Johnson: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Johnson & Johnson: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Johnson & Johnson: M&A Average Deal Size - Value (US$m)
Figure 4: Johnson & Johnson: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Johnson & Johnson: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Johnson & Johnson: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Johnson & Johnson: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Johnson & Johnson: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Johnson & Johnson: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Johnson & Johnson：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Caldic B.V.：企業の戦略・SWOT・財務情報
    Caldic B.V. - Strategy, SWOT and Corporate Finance Report Summary Caldic B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Quest Diagnostics Incorporated：戦略・SWOT・企業財務分析
    Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SK Biopharmaceuticals Co Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Michelin SCA (ML)：企業の財務・戦略的SWOT分析
    Michelin SCA (ML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Larsen & Toubro Ltd (LT)：企業の財務・戦略的SWOT分析
    Larsen & Toubro Ltd (LT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sopharma AD (3JR)：企業の財務・戦略的SWOT分析
    Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Iterum Therapeutics Plc (ITRM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Iterum Therapeutics Plc (Iterum Therapeutics) is a clinical-stage pharmaceutical company which develops anti-infectives for multi-drug resistant (MDR) pathogens for treating serious and life-threatening diseases. The company is developing Sulopenem, an oral and IV targeted-spectrum penem ant …
  • Mitsubishi Materials Corporation：企業のM&A・事業提携・投資動向
    Mitsubishi Materials Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Materials Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Kindred Healthcare, Inc.：戦略・SWOT・企業財務分析
    Kindred Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kindred Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cytodyn Inc (CYDY)：企業の財務・戦略的SWOT分析
    Summary Cytodyn Inc (Cytodyn), formerly RexRay Corp, is a biotechnology company. It develops and commercializes monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. It is investigating Leronlimab (PRO 140), a fully humanized IgG4 monoclonal antibody directed agai …
  • Steel Authority of India Ltd：企業の戦略・SWOT・財務情報
    Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • RWE AG：企業の発電所・SWOT分析2018
    RWE AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Noile-Immune Biotech Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Noile-Immune Biotech Inc (Noile-Immune Biotech) is a clinical stage biotechnology company that develops and commercializes next generation CAR-T cell therapies for the treatment of cancer. The company works in collaboration with National Cancer Center Japan and Yamaguchi University to develo …
  • Verax Biomedical Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Verax Biomedical Inc (Verax) is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD tech …
  • Leukocare AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • Datang International Power Generation Co Ltd (991)：企業の財務・戦略的SWOT分析
    Datang International Power Generation Co Ltd (991) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Raschig GmbH：企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ben E. Keith Co：企業の戦略的SWOT分析
    Ben E. Keith Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Equinor ASA (EQNR)：企業の財務・戦略的SWOT分析
    Equinor ASA (EQNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Rothschild Bank Ag：企業の戦略・SWOT・財務分析
    Rothschild Bank Ag - Strategy, SWOT and Corporate Finance Report Summary Rothschild Bank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆